Article Text

Download PDFPDF

Response to ‘What rheumatologist should know about Fabry disease’ by Moiseev et al
Free
  1. Stefan Vordenbäumen1,
  2. Ralph Brinks1,
  3. Jutta G Richter1,
  4. Katinka Albrecht2,
  5. Matthias Schneider1
  1. 1 Rheumatology and Hiller Research Unit, Heinrich-Heine-University Düsseldorf, Medical Faculty, Düsseldorf, Germany
  2. 2 DRFZ, Berlin, Germany
  1. Correspondence to Dr Stefan Vordenbäumen, Rheumatology, Heinrich-Heine-University, Duesseldorf 40225, Germany; stefan.vordenbaeumen{at}med.uni-duesseldorf.de

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

In their correspondence1 to our study on the prevalence of Fabry disease (FD) within a national cohort of early undifferentiated arthritis patients in Germany,2 Moiseev et al raise additional issues of importance for clinical rheumatologists pertaining to the change of symptoms in FD over time.

Retrospective studies analysing the medical history of patients with confirmed FD raised concerns that FD may be overlooked in rheumatological practice. In particular, Lidove et al reported that 9 of 40 patients were mistakenly diagnosed with a rheumatic condition in adulthood prior to the diagnosis of FD.3 This is well in line with the data reported by Moiseev …

View Full Text

Linked Articles

  • Correspondence
    Sergey Moiseev Ekaterina Karovaikina Pavel I Novikov Dilyara Ismailova Alexey Moiseev Nikolai Bulanov